Baxter International Inc
BAX- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000010456
No open-market purchases or sales by Baxter International Inc insiders were filed in the last 90 days; 689 institutions reported holding it in 13F filings for Q2 2026, worth $11.9B in total; Greenhaven Associates is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Baxter International Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 941
- +37 vs. Q4 2023
- Shares held
- 458.1M
- +688.5K (+0.2%) vs. Q4 2023
- Total value
- $19.6B
- +$1.89B (+10.7%) vs. Q4 2023
- New holders
- 117
- 314 more added
- Sold out
- 80
- 323 more reduced
14 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BAX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 689 | $11.9B |
| Q1 2026 | 664 | $8.88B |
| Q4 2025 | 711 | $10.5B |
| Q3 2025 | 733 | $11.5B |
| Q2 2025 | 775 | $15.1B |
| Q1 2025 | 843 | $16.8B |
| Q4 2024 | 829 | $14.1B |
| Q3 2024 | 906 | $17.8B |
| Q2 2024 | 885 | $15.2B |
| Q1 2024 | 941 | $19.6B |
| Q4 2023 | 918 | $17.7B |
| Q3 2023 | 912 | $16.9B |
| Q2 2023 | 985 | $20.1B |
| Q1 2023 | 959 | $17.9B |
| Q4 2022 | 1,013 | $22.2B |
| Q3 2022 | 1,013 | $23.6B |
| Q2 2022 | 1,075 | $27.8B |
| Q1 2022 | 1,148 | $33.5B |
| Q4 2021 | 1,162 | $36.8B |
| Q3 2021 | 1,093 | $34.4B |
| Q2 2021 | 1,114 | $34.6B |
| Q1 2021 | 1,097 | $36.8B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Baxter International Inc; share changes are against Q4 2023.